Register Now for the 16th Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data Analysis. on February 16-19, 2015 in San Diego, CA

From: Alicia Holmes Date: August 22, 2014 event Source: mail-archive.com
Dear Colleague, You are invited to join Dr. Daniel Weiner for the 16th Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data Analysis.. Learn to apply advanced approaches for conducting PK/PD analysis. This course has updated content, hands-on problem solving that will include an introduction to population PK/PD modeling. Topics include: Dose-response-time analysis, advanced principles of turnover modeling including modeling tolerance and rebound, approaches to TMDD modeling, approaches to optimizing sampling collection times, modeling PD effects for combination drug treatments, pattern recognition, and translational aspects of PK/PD modeling. Course includes: * Complimentary copy of Pharmacokinetic & Pharmacodynamic Data Analysis [with CDROM] by Daniel Weiner. * Lectures, group exercises with discussion, and hands-on PK/PD data analysis including population PK/PD modeling using Phoenix WinNonlin and NLME. * Discussions and exercises will enable participants to master state-of-the-art approaches to real-life problems. Who should attend? Scientists with at least five years of experience in PK/PD modeling Don't miss this opportunity to increase your confidence in understanding basic and advanced approaches to PK/PD modeling and to apply these approaches using population methods. Sign up today! 20% early registration discount (Expires December 15, 2014) 30% off of groups 50% off for students Register Now https://www.certara.com/training/classes/72 Special rates available at the Courtyard Marriott, http://www.marriott.com/hotels/travel/sanot-courtyard-san-diego-old-town/ if reserved by January 15 2015. Please ask for the Certara Meeting rate. Daniel Weiner Ph.D. Dr. Weiner has extensive drug development experience and has served as an expert consultant to the U.S. Food and Drug Administration (FDA) on pharmacokinetic modeling and bioequivalence assessment. Prior to his previous tenure with Pharsight as a Senior Vice President, Dr. Weiner held several management positions including Head, Biostatistics, Merrell Dow Pharmaceuticals; Vice President, Statistical Consultants, Inc.; Vice President, Syntex Development Research; Senior Vice President and Principal Scientist, Quintiles, and most recently, Senior Vice President and Global Head of Clinical Development at IVAX Research. Johan Gabrielsson Johan Gabrielsson has been Senior Principal Scientist at AstraZeneca R&D Mölndal. His responsibilities included kinetic/dynamic related project tasks in the CV & GI & CNS & Cancer & Biologics areas. He is a co-author of the textbook 'Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications' 4th ed. (2006). He is professor of Integrative Pharmacology at the Swedish Agricultural University in Uppsala, Sweden. He is also academically affiliated with Dept. of Pharmaceutics, Univ. Tennessee and University of Manchester. He has published extensively in the field of pharmacokinetic-pharmacodynamic modelling and reasoning, and has run numerous courses internally and externally in the area of biological data analysis since 1985 in Europe, the US and Asia (>4000 participants) at both the undergraduate and graduate level. His research focuses on modelling different aspects of endogenous turnover, such as functional tolerance and rebound phenomena, physiological limits and target-mediated drug disposition in collaboration with Professor LA Peletier, Leiden University. He has been external examiner on several PhD Theses abroad. Alicia Holmes Sales Support Specialist Certara(tm) Implementing Translational Science 210 N. Tucker Blvd., Suite 350, St. Louis, MO 63101 Tel 314-951-3012 Fax 314-951-3099 Certara: The name behind the names you know Tripos - Simcyp - Pharsight http://www.certara.com/